These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 34479918)
1. The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells. Mohiuddin M; Kasahara K Cancer Genomics Proteomics; 2021; 18(5):661-673. PubMed ID: 34479918 [TBL] [Abstract][Full Text] [Related]
2. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer. Sun C; Gao W; Liu J; Cheng H; Hao J Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129 [TBL] [Abstract][Full Text] [Related]
3. Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET. Oh HN; Lee MH; Kim E; Kwak AW; Yoon G; Cho SS; Liu K; Chae JI; Shim JH Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32070026 [TBL] [Abstract][Full Text] [Related]
4. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET. Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin Activates the Growth Inhibitory Signaling Pathways by Enhancing the Production of Reactive Oxygen Species in Non-small Cell Lung Cancer Carrying an EGFR Exon 19 Deletion. Mohiuddin M; Kasahara K Cancer Genomics Proteomics; 2021; 18(3 Suppl):471-486. PubMed ID: 33994369 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Impedes EGFR-mutated PC9 Cell Growth Mohiuddin M; Kasahara K Cancer Genomics Proteomics; 2021; 18(5):645-659. PubMed ID: 34479917 [TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis. Yu B; Zheng L; Tang H; Wang W; Lin Y Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396444 [TBL] [Abstract][Full Text] [Related]
8. GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway. Wang L; Liu J; Liu J; Chen X; Chang M; Li J; Zhou J; Bai C; Song Y J Cancer Res Clin Oncol; 2019 Apr; 145(4):861-872. PubMed ID: 30661098 [TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of c-MET by podophyllotoxin promotes caspase-dependent apoptosis and suppresses cell growth in gefitinib-resistant non-small cell lung cancer cells. Oh HN; Kwak AW; Lee MH; Kim E; Yoon G; Cho SS; Liu K; Chae JI; Shim JH Phytomedicine; 2021 Jan; 80():153355. PubMed ID: 33039730 [TBL] [Abstract][Full Text] [Related]
10. Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells. Nam AY; Joo SH; Khong QT; Park J; Lee NY; Lee SO; Yoon G; Park JW; Na M; Shim JH Sci Rep; 2024 Sep; 14(1):20820. PubMed ID: 39242647 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells. Zhu Y; He W; Gao X; Li B; Mei C; Xu R; Chen H Sci Rep; 2015 Dec; 5():17730. PubMed ID: 26635117 [TBL] [Abstract][Full Text] [Related]
12. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway. Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022 [TBL] [Abstract][Full Text] [Related]
13. Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer. Yang Q; Chen W; Xu Y; Lv X; Zhang M; Jiang H Toxicol Appl Pharmacol; 2018 Oct; 356():1-7. PubMed ID: 30076870 [TBL] [Abstract][Full Text] [Related]
14. PCK2 induces gefitinib resistance by suppresses ferroptosis in non-small cell lung cancer. Yan T; Zhang N; Liu F; Wang H; Zhang J; Jin X; Jiang S Biochem Biophys Res Commun; 2024 Sep; 723():150200. PubMed ID: 38850814 [TBL] [Abstract][Full Text] [Related]
15. P1-39: Paclitaxel induces growth inhibition in gefitinib-resistant PC9-MET cells by downregulating MDM2 and activating p53. Respirology; 2021 Nov; 26 Suppl 3():87. PubMed ID: 34799910 [No Abstract] [Full Text] [Related]
16. β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells. Fang X; Gu P; Zhou C; Liang A; Ren S; Liu F; Zeng Y; Wu Y; Zhao Y; Huang B; Zhang Z; Yi X Pulm Pharmacol Ther; 2014 Jun; 28(1):41-48. PubMed ID: 23707949 [TBL] [Abstract][Full Text] [Related]
17. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer. Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272 [TBL] [Abstract][Full Text] [Related]
18. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells. Han SY; Zhao MB; Zhuang GB; Li PP Lung Cancer; 2012 Jan; 75(1):30-7. PubMed ID: 21757251 [TBL] [Abstract][Full Text] [Related]
19. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621. Chen ZY; Liu HY; Jiang N; Yuan JM Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer. Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]